Related Experiment Video
Updated: Jul 29, 2025

06:03
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
6.7K
Validation Study on Risk-Reduction Activities after Exposure to a Personalized Breast Cancer Risk-Assessment
Tianyi Wang1,2, Mandy Che1,3, Yash S Huilgol4
1UC San Francisco Department of Surgery, San Francisco, USA.
Research Square
|May 22, 2023
Summary
The Breast Health Decisions tool improved uptake of lifestyle changes for breast cancer risk reduction. However, healthcare provider barriers may limit the use of endocrine medications for high-risk women.
Area of Science:
- Oncology
- Preventive Medicine
- Health Communication
Background:
- Breast cancer risk assessment is crucial for guiding preventive strategies.
- The Women Informed to Screen Depending on Measures of risk (WISDOM) trial investigated personalized screening.
- Effective risk communication tools are needed for high-risk individuals.
Approach:
- A validation study assessed the Breast Health Decisions (BHD) tool in 318 high-risk women from the WISDOM trial.
- The BHD tool uses patient-friendly visuals and simple language to explain risk and prevention.
- Participants were assessed before and three months after using the BHD tool.
Key Points:
- Prior to BHD use, 4.7% used endocrine risk reduction, 38.7% reduced alcohol, and 62.6% increased exercise.
- After BHD, uptake increased: 8.4% considered endocrine risk reduction, 33% considered alcohol reduction, and 46% considered exercise.
- While lifestyle intervention uptake improved, endocrine risk reduction medication use showed less significant change.
Conclusions:
- The BHD tool effectively promotes patient engagement with lifestyle modifications for breast cancer risk reduction.
- Healthcare provider-level barriers may hinder the optimal use of endocrine risk reduction medications in high-risk populations.
- Further research is needed to address systemic barriers to prescribing preventive endocrine therapy.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
151
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
151
Relative Risk
251
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
251
Hazard Ratio
170
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
170
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Cancer-Critical Genes II: Tumor Suppressor Genes
7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K

